Legal Representation
Attorney
John R. Schaefer
USPTO Deadlines
Next Deadline
968 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-03-29)
Due Date
March 29, 2028
Grace Period Ends
September 29, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
32 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Feb 14, 2025 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
Nov 8, 2024 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
Mar 7, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
Mar 7, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Mar 7, 2023 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
Mar 7, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Mar 7, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Mar 7, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
Sep 12, 2022 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
Aug 22, 2022 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
Aug 22, 2022 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
Jun 29, 2022 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
Mar 29, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Jan 11, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Jan 11, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Jan 10, 2022 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
Dec 22, 2021 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
Dec 22, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Dec 22, 2021 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
Dec 3, 2021 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Nov 4, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Nov 3, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Nov 3, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Oct 30, 2021 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
Oct 6, 2021 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
Oct 6, 2021 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
Sep 22, 2021 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
Sep 21, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Sep 21, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Apr 27, 2021 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
Apr 23, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Apr 22, 2021 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 001
Chemical and biological substances in the nature of chemicals for use in science and industry; nucleic acids for laboratory use; nucleic recombinant acids for laboratory use, synthetic deoxyribonucleic acids for laboratory use; chemical and biological reagents for non-medical purposes; chemical and biological reagents for scientific and research purposes; human or animal cells and parts thereof for non-medical purposes; microorganisms for non-medical purposes; human or animal cells and parts thereof for scientific and research purposes; microorganisms for scientific and research purposes; viral vectors for use in science and industry
Class 005
Chemical and biological reagents for medical and veterinary use; diagnostic and test reagents for medical and veterinary use; human or animal cells and parts thereof for medical and veterinary purposes; microorganisms for medical and veterinary purposes; viral vectors for medical and veterinary purposes
Class 042
Design services relating to the creation and alteration of chemical and biological reagents in the nature of custom design and development of chemical reagents and biochemical assays; design services relating to the creation and alteration of nucleic recombinant acids and synthetic deoxyribonucleic acids in the nature of custom design and development of nucleic recombinant acids and synthetic deoxyribonucleic acids; design services relating to the creation and alteration of recombinant viruses, namely, scientific development of recombinant viruses; design services relating to the creation and alteration of antibodies, namely, scientific development of antibodies; design services relating to the creation and alteration of cell lines, elementary cells and parts thereof, namely, scientific development of cell lines, elementary cells and structural parts thereof; design services relating to the creation and alteration of viral vectors, namely, scientific development of viral vectors; information and advice relating to all the aforesaid services
Classification
International Classes
001
005
042